87
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical Course of Patients With Aspirin-Exacerbated Respiratory Disease: Can we Predict the Prognosis?

, , , , , & show all
Pages 449-457 | Published online: 13 Mar 2014

References

  • Palikhe NS , KimJH, ParkHS. Update on recent advances in the management of aspirin exacerbated respiratory disease. Yonsei Med. J.50(6) , 744–750 (2009).
  • Park SM , ParkJS, ParkHS, ParkCS. Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways. Allergy Asthma Immunol. Res.5(5) , 258–276 (2013).
  • Park HS , KimSH, SampsonAP, LeeKW, ParkCS. The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma. J. Allergy Clin. Immunol.114(3) , 688–689 (2004).
  • Kim SH , YeYM, LeeSK et al. Association of TNF-alpha genetic polymorphism with HLA DPB1*0301. Clin. Exp. Allergy 36(10) , 1247–1253 (2006).
  • Kim SH , ChoiJH, HollowayJW et al. Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population. J. Korean Med. Sci. 20(6) , 926–931 (2005).
  • Song YS , YangEM, KimSH, JinHJ, ParkHS. Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease. Int. Arch. Allergy Immunol.159(2) , 157–161 (2012).
  • Kim SH , YangEM, ParkHJ, YeYM, LeeHY, ParkHS. Differential contribution of the CysLTR1 gene in patients with aspirin hypersensitivity. J. Clin. Immunol.27(6) , 613–619 (2007).
  • Park JS , ChangHS, ParkCS et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet. Genomics 15(7) , 483–492 (2005).
  • Kim SH , ChoiJH, ParkHS et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin. Exp. Allergy 35(5) , 585–590 (2005).
  • Kim SH , YangEM, LeeHN, ChoBY, YeYM, ParkHS. Combined effect of IL-10 and TGF-beta1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitis. Allergy64(8) , 1221–1225 (2009).
  • Palikhe NS , KimSH, ChoBY et al. IL-13 gene polymorphisms are associated with rhinosinusitis and eosinophilic inflammation in aspirin intolerant asthma. Allergy Asthma Immunol. Res.2(2) , 134–140 (2010).
  • Kim SH , YangEM, LeeHN, ChoiGS, YeYM, ParkHS. Association of the CCR3 gene polymorphism with aspirin exacerbated respiratory disease. Respir. Med.104(5) , 626–632 (2010).
  • Palikhe NS , KimSH, ChoBY, YeYM, ChoiGS, ParkHS. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy65(3) , 338–346 (2010).
  • Stevenson DD , SzczeklikA. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J. Allergy Clin. Immunol.118(4) , 773–786, quiz 787–778 (2006).
  • Mascia K , HaselkornT, DenizYM, MillerDP, BleeckerER, BorishL. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J. Allergy Clin. Immunol.116(5) , 970–975 (2005).
  • Park HS . Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. Clin. Exp. Allergy25(1) , 38–40 (1995).
  • Bateman ED , HurdSS, BarnesPJ et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 31(1) , 143–178 (2008).
  • Nizankowska-Mogilnicka E , BochenekG, MastalerzL et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62(10) , 1111–1118 (2007).
  • Shrestha Palikhe N , KimSH, JinHJ, HwangEK, NamYH, ParkHS. Genetic mechanisms in aspirin-exacerbated respiratory disease. J. Allergy (Cairo)2012 , 794890 (2012).
  • Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am. J. Respir. Crit. Care Med.162(6) , 2341–2351 (2000).
  • Szczeklik A , NizankowskaE, DuplagaM. Natural history of aspirin-induced asthma. AIANE investigators. European Network on Aspirin-Induced Asthma. Eur. Respir. J.16(3) , 432–436 (2000).
  • Berges-Gimeno MP , SimonRA, StevensonDD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann. Allergy Asthma Immunol.89(5) , 474–478 (2002).
  • White AA , StevensonDD, SimonRA. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann. Allergy Asthma Immunol.95(4) , 330–335 (2005).
  • White A , LudingtonE, MehraP, StevensonDD, SimonRA. Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann. Allergy Asthma Immunol.97(5) , 688–693 (2006).
  • Park JS , JangAS, ParkSW et al. Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics. Allergy Asthma Immunol. Res. 2(1) , 48–54 (2010).
  • Szczeklik A , DworskiR, MastalerzL et al. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. Am. J. Respir. Crit. Care Med. 158(4) , 1168–1172 (1998).
  • Wegmann M , GoggelR, SelS et al. Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma. Am. J. Respir. Cell Mol. Biol. 36(1) , 61–67 (2007).
  • Adamjee J , SuhYJ, ParkHS et al. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. J. Pathol. 209(3) , 392–399 (2006).
  • Yao T , KojimaY, KoyanagiA et al. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. Laryngoscope 119(6) , 1053–1059 (2009).
  • Nizankowska E , Bestynska-KrypelA, CmielA, SzczeklikA. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur. Respir. J.15(5) , 863–869 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.